Professional Documents
Culture Documents
Curriculum Vitae
B. Education
1. Undergraduate Education
1989 - 1993 B.A., Economics, cum laude, Williams College, Williamstown,
MA
3. Postgraduate Training
2002 - 2005 Fellowship, PGY 4-6 Pediatric Hematology-Oncology
Fellowship, Baylor College of Medicine; Texas Children’s
Hospital, Department of Pediatrics, Houston, Texas
1999 - 2001 Residency, The University of Chicago, Pritzker School of
Medicine, PGY 1-3 Pediatric Residency: Department of
Pediatrics, Chicago, Illinois
C. Academic Appointments
1. Faculty Position(s) at BCM
7/1/2018 - Present Fellowship Director, Pediatric Hematology-Oncology, Baylor
College of Medicine
7/1/2017 - Present Associate Professor of Pediatrics, Pediatrics, Baylor College of
Medicine
7/2009 - Present Associate Director of the Education Division, Pediatric
Hematology-Oncology, Baylor College of Medicine
7/2008 - Present Chair of the Program Evaluation Committee, Pediatric
Hematology-Oncology, Baylor College of Medicine
7/1/2008 – 6/30/2018 Associate Fellowship Director, Pediatric Hematology-Oncology,
E. Other Information
1. Honors or Awards
2018 Norton Rose Fulbright, Faculty Excellence Award, Teaching and Evaluation,
Baylor College of Medicine
2015 Fulbright & Jaworski, L.L.P. Faculty Excellence Award, Educational
Leadership, Baylor College of Medicine
2012 Faculty Recognition Award for Excellence in Teaching , Texas Children’s
Cancer and Hematology Centers
2012 Member, Baylor College of Medicine Distinguished Educator Academy,
Baylor College of Medicine
2012 Fulbright & Jaworski, L.L.P. Faculty Excellence Award, Teaching and
Evaluation, Baylor College of Medicine
2. Board Eligibility/Certification
10/2006 Sub-Board of Pediatric Hematology-Oncology, American Board of Pediatrics
8/2005 Texas Board of Medical Examiners, License #M0790
10/2001 American Board of Pediatrics
2. Review Panels
2019 - Present Reviewer, Pediatric Blood and Cancer
2019 - Present Reviewer, Journal of Pediatric Hematology and Oncology
3. Professional Societies
2015 - Present Association of Pediatric Program Directors
2002 - Present American Society of Hematology
2002 - Present American Society of Pediatric Hematology and Oncology
1998 - Present American Academy of Pediatrics
2007 - 2012 Hemostasis and Thrombosis Research Society
4. Elected Positions
National / 2019 - Present Member, American Society of Pediatric
International Hematology and Oncology Training
Committee
b. National
Speaker, Early Career Roundtable Session- Clinician Educator Track, American Society
of Pediatric Hematology-Oncology Annual Meeting, May 2020
c. Regional
Speaker, “Hematologic Disorders Associated with Albinism”. National Organization for
Albinism and Hypopigmentation. Houston, TX, September 2010
C. Publications
1. Full Papers in Peer Review Journals
a. Published
1. Dinh CN, Moffett BS, Galati M, Lee-Kim Y, Yee DL, Mahoney D. A Critical
Evaluation of Enoxaparin Dose Adjustment Guidelines in Children. J Pediatr
Pharmacol Ther, 24(2):128-133, Mar 2019. PMID 31019405, PMC6478360
2. Lindsay H, Bhar S, Bonifant C, Sartain S, Whittle SB, Lee-Kim Y, Shah MD. Work
efficiency improvement of >90% after implementation of an annual inpatient blood
products administration consent form. BMJ Open Qual, 7(1):e000164, Jan 2018.
PMID 29333497, PMC5759742
3. Moffett BS, Galati M, Mahoney D, Lee-Kim Y, Teruya J, Shah MD, Yee DL.
Enoxaparin Population Pharmacokinetics in the First Year of Life. Ther Drug Monit,
39(6):632-639, Dec 2017. PMID 28937536
4. Moffett BS, Lee-Kim Y, Galati M, Mahoney D, Shah MD, Teruya J, Yee D.
Population Pharmacokinetics of Enoxaparin in Pediatric Patients. Ann
Pharmacother, 52(2):140-146, Sep 2017. PMID 28962537
5. Fan JL, Roberts LE, Scheurer ME, Yee DL, Shah MD, Lee-Kim YJ. Association of
outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolism.
Pediatr Blood Cancer, May 2017. PMID 28521068
6. Dietrich JE, Yee DL, Santos XM, Bercaw-Pratt JL, Kurkowski J, Soni H, Lee-Kim YJ,
Shah MD, Mahoney D, Srivaths LV. Assessment of an Electronic Intervention in
Young Women with Heavy Menstrual Bleeding. J Pediatr Adolesc Gynecol,
30(2):243-246, Oct 2016. PMID 27751907
7. Lindsay H, Lee-Kim YJ, Srivaths LV. Perioperative Hemostatic Management in
Ehlers-Danlos Syndrome: A Report of 2 Cases and Literature Review. J Pediatr
Hematol Oncol, 38(2):158-60, Mar 2016. PMID 26334432
8. Lindsay H, Lee-Kim YJ, Srivaths LV. Perioperative Hemostatic Management in
Ehlers-Danlos Syndrome: A Report of 2 Cases and Literature Review Journal of
Pediatric Hematology-Oncology, 2(38):158-60, Mar 2016. PMID
9. Beaty RS, Moffett BS, Mahoney DH, Yee DL, Lee-Kim YJ. Use of 4-Factor
Prothrombin Concentrate (Kcentra) in Hospitalized Pediatric Patients. Ann
Pharmacother, 50(1):70-1, Oct 2015. PMID 26497886
10. O'Brien MM, Lee-Kim Y, George TI, McClain KL, Twist CJ, Jeng M. Precursor B-cell
acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis.
Pediatr Blood Cancer, 50(2):381-3, Feb 2008. PMID 16856156
b. Accepted/In Press
Not applicable.
b. Accepted/In Press
Not applicable.
c. Submitted
Not applicable.
b. National
1. Stuckert A, Bertrand K, Campbell M, Gilbert M, Hsieh E, Mangum M, Lee-Kim Y.
FoPHO: Improving Fellow Education Using a Learner-Centered, Learner-Driven
Approach, American Society of Pediatric Hematology-Oncology, May 2020
2. Hsieh E, Conneely S, Teruya J, Nicholas S, Lee-Kim Y Blood, Sweat, and Fears:
Allergic Reaction and Lack of Response to Fibrinogen Replacement Therapy in a
Patient with Afibrinogenemia American Society of Pediatric Hematology-Oncology,
May 2019
3. Lee-Kim Y, Whittle S, Porea T, Frugé E, Gramatages M Strategies for Implementing
an Effective Morbidity Mortality and Improvement (MMI) Conference American
Society of Pediatric Hematology-Oncology, May 2018
4. Diaz R, Lee-Kim Y Transition clinic for adolescents on chronic anticoagulation
American Society of Pediatric Hematology-Oncology, Apr 2017
5. Sahnoune I, Lee-Kim Y, Beaty R, Mahoney DM, Yee DL Prophylactic Enoxaparin
Use in Pediatrics: Pharmacologic, Radiographical and Clinical Outcomes. American
Society of Pediatric Hematology-Oncology, May 2016
6. Lee-Kim YJ, Frugé ED, Turner TL, Scheurer ME, Steuber CP. Fellow Onboarding
Association of Pediatric Program Directors, Mar 2016
c. Regional
Not applicable.
d. Local
Moonat H, Lee-Kim Y, Shapiro M. Development of a Subspecialty Continuity Clinic
e. Other
Not applicable.
4. Books
a. Complete Books Written
Not applicable.
b. Books Edited
Not applicable.
3. Other Activities
Not applicable.
B. Didactic Coursework
1. Courses Taught at BCM Within the Primary Department
2012 - 2018 “Hollywood Squares: Platelet and White Blood Cell Disorders”,
Baylor College of Medicine
2010 - 2012 “Platelet Disorders”, Baylor College of Medicine
2006 - 2018 “Coagulation Disorders”, Baylor College of Medicine
2. National
3. Regional
1. “Hematologic Disorders Associated with Albinism”, National Organization for
Albinism and Hypopigmentation, Houston, TX, 2010.
4. Local
1. Facilitator for STaRS (Safety and Teaching as Resident Supervisors), Baylor
College of Medicine, Jan 2020
2. Facilitator for Faculty College Workshop on Role Modeling “How to Be a
Supermodel”, Baylor College of Medicine, Oct 2018, Feb 2020
3. Speaker for Pediatric Residency: Senior’s Day Career Breakout Session “Planning
for Fellowship”, Baylor College of Medicine, Sep 2017
4. Speaker for Fellows College Seminar “Academic Pathways”
Baylor College of Medicine, Aug 2017
5. Facilitator for Fellows’ College Seminar “Professionalism”, Baylor College of
Medicine, Jul 2016
6. Facilitator for CLASS (Clinician, Leadership, Scholarship, Success) Program, Baylor
College of Medicine, Apr 2016.
7. “Preparing for the Pediatric Hematology-Oncology Boards”, Pediatric Hematology-
Oncology Fellows Meeting, Oct 2015.
8. “Congenital Thrombocytopenias”, Texas Children’s Hospital, Sep 2014.
9. “AV Fistulas for Hemophilia”, Hematology Case Conference, Texas Children’s
Hospital, Aug 2014.
10. “Appropriate Use of Electronic Communication in Medicine”, Pediatric Hematology-
Oncology Faculty Meeting and Fellows Meeting, Aug 2014.
11. “Understanding ACGME Milestone-Based Evaluations”, Pediatric Hematology-
Oncology Faculty Meeting and Fellows Meeting, Aug 2014.
12. “Hemorrhagic Transformation in Pediatric Arterial Ischemic Stroke”, Hemostasis and
Thrombosis Journal Club, Hemostasis and Thrombosis Journal Club, Sep 2012.
13. “Hemophilia and Inhibitors”, Coagulation and Hematology CME Conference, Texas
Children’s Hospital, Apr 2012.
14. “Off-Label Use of Recombinant Factor VIIa”, Hemostasis and Thrombosis Journal
Club, Texas Children’s Hospital, Jan 2011.
15. “Athletic Participation in Severe Hemophilia”, Hemostasis and Thrombosis Journal
Club, Texas Children’s Hospital, Feb 2010.
16. “Bleeding in ENT Surgeries”, Multidisciplinary Hematology Case Conference, Texas
Children’s Hospital, Oct 2009.
17. “Severe Aplastic Anemia”, Hematology Case Conference, Texas Children’s Hospital,
Oct 2008.
18. “Autoimmune Hemolytic Anemia”, Coagulation and Hematology CME Conference,
Texas Children’s Hospital, Aug 2008.
19. “Ligneous Conjunctivitis”, Hematology Case Conference, Texas Children’s Hospital,
Jun 2008.
5. Other
Not applicable.
G. Visiting Professorships
Not applicable.
2. Section or Specialty
2007 - Present Baylor Pediatric Program, Hemostasis and Thrombosis Consult
Service
Attending physician for inpatient hemostasis and thrombosis
consultations to Baylor Pediatric Program
6 weeks per year
2005 - Present Pediatric Hematology-Oncology Outpatient Clinic, Teaching of
students, residents, and fellows occurs in this venue.
2 days per week
3. Clinical Service
Not applicable.
V. Service Contributions
A. Administrative Assignments and Committees
1. Department Administration, Committees
Not applicable.
2. Community Service: